Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Axonal damage in multiple sclerosis: a complex issue in a complex disease.

Nikolaos Grigoriadis1, Tamir Ben-Hur, Dimitrios Karussis

  • 1Department of Neurology, AHEPA University Hospital, Aristotle University of Thessaloniki, 1 Stilp. Kyriakidi Str., 54636 Thessaloniki, Greece. grigoria@med.auth.gr

Clinical Neurology and Neurosurgery
|June 5, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Building Towards Initiation, Moderation, De-Escalation and Cessation of Disease-Modifying Treatments for Multiple Sclerosis in Greece: An Expert Panel Consensus Meeting.

Brain sciences·2026
Same author

A neurologist's guide to VEXAS syndrome: Differentiating somatic autoinflammation from autoimmune mimics.

Intractable & rare diseases research·2026
Same author

Exploring the Personalisation of Digital Cognitive Rehabilitation in Multiple Sclerosis Through Wearable Data and Machine Learning.

Studies in health technology and informatics·2026
Same author

Development and expert refinement of a stratified framework for progression independent of relapse activity (PIRA) in multiple sclerosis.

Clinical neurology and neurosurgery·2026
Same author

Predicting disease progression in multiple sclerosis with clinically accessible information and technology.

Journal of neurology·2026
Same author

High-intensity exercise training alters gut microbiota to mitigate the development of experimental autoimmune encephalomyelitis.

Scientific reports·2026

Multiple sclerosis involves axonal destruction, not just demyelination, contributing to disability. Future therapies may focus on neuroprotection and remyelination to shield axons.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Multiple sclerosis (MS) is increasingly recognized beyond its autoimmune demyelinating nature.
  • Axonal destruction is a key pathological feature in MS, driving progressive disability.
  • The precise mechanisms of axonal pathology in MS remain incompletely understood.

Purpose of the Study:

  • To investigate the complex pathology of multiple sclerosis.
  • To explore the relationship between axonal damage and other MS pathological features.
  • To highlight potential therapeutic avenues for neuroprotection in MS.

Main Methods:

  • Review of current understanding of MS pathology.
  • Analysis of experimental data on axonal damage and remyelination.

Related Experiment Videos

  • Investigation into the interplay between demyelination, inflammation, and axonal integrity.

    • Main Results:

    • Axonal destruction is a central pathological feature in MS, contributing significantly to disability.
    • The mechanisms driving axonal pathology are complex and multifactorial.
    • Experimental evidence suggests rapid remyelination may offer axonal protection.

    Conclusions:

    • Future therapeutic strategies for MS should consider neuroprotection alongside immunomodulation.
    • Targeting remyelination may be a promising approach to preserve axons in MS.
    • A comprehensive understanding of MS pathology is crucial for developing effective treatments.